Physician profile
Andrew Richardson
NPI 1457856551
$7,295.79
in general payments reported to CMS, 2019-2025
8 companies · $2,846 in 2025
The $2,846 reported for 2025 was more than what 79% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,450 · 2025: $2,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,084 · Travel and Lodging: $2,337 · Consulting Fee: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,083.77 |
| Travel and Lodging | $2,337.02 |
| Consulting Fee | $1,875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,038.55 | 2024-2025 | Obsidio, Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered |
| Penumbra, INC. | $2,122.68 | 2024 | Indigo System |
| Abbott Laboratories | $1,622.77 | 2024 | Optis, Supera |
| Trisalus Life Sciences, INC. | $219.29 | 2024 | Trinav Infusion System |
| Terumo Medical Corporation | $187.25 | 2024-2025 | Azur Cx Detachable, Angio-Seal |
| Stryker Corporation | $48.11 | 2025 | Flowtriever |
| Medtronic, INC. | $33.71 | 2024 | Concertotm |
| Angiodynamics, INC. | $23.43 | 2025 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.